Gestational Diabetes Mellitus
Conditions
Keywords
Foetal glycated hemoglobin, Glycemic objectives treatment
Brief summary
In a previous study, the investigators established the dosage of foetal glycated hemoglobin (FGH). It represents the mean of blood sugar 4-6 before the delivery. The investigators also compared the FGH of newborn of women with and without gestational diabetes mellitus (GDM) and determined that newborn of women with GDM had significantly higher FGH that newborn of women without GDM. In this study, the investigators want to compare the FGH of newborn of GDM women randomized to a group reaching the Canadian Diabetes Association recommended blood glucose objectives treatment (fasting: 5.3 mmol/L and 2-hour after meals: 6.7 mmol/L) to a group reaching lower blood glucose objectives (fasting: 4.8 mmol/L and 2-hour after meals: 5.9 mmol/L)
Interventions
PROCEDURENormal glycemic control
Use diet, physical exercise of insulins to reach normal glycemic control.
PROCEDURELow glycemic control
Use diet, physical exercise of insulins to reach low glycemic control.
Sponsors
Université de Sherbrooke
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* gestational age between 15 and 32 weeks since last menstrual date, * received education on gestational diabetes mellitus, * able to read and understand French.
Exclusion criteria
* known type 1 or type 2 diabetes, * treatment interfering woth glucose metabolism, * deficit may hinder the understanding of the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Foetal glycated hemoglobin | At delivery |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Treatment satisfaction | End of pregnancy | Evaluated by questionnaire |
Countries
Canada
Outcome results
None listed